Association of Red Blood Cell Indices with Mild Cognitive Impairment in Chinese Elderly Individuals: A Matched

Yue Du1, Mengdi Jin1, Qian Liu1

  • 1Tianjin Key Laboratory of Environment, Nutrition and Public Health, Tianjin, China.

Current Alzheimer Research
|February 19, 2021
PubMed
Abstract

Insights

Red blood cell indices, specifically hemoglobin (HGB) and red cell distribution width-standard deviation (RDW-SD), show promise for detecting mild cognitive impairment (MCI). Combining HGB and RDW-SD offers high accuracy in identifying MCI in elderly Chinese individuals.

Area of Science:

  • Gerontology and Cognitive Neurology
  • Hematology and Biomarker Discovery

Background:

  • Mild cognitive impairment (MCI) is a critical transitional stage between normal aging and dementia.
  • There is a significant need for accessible, non-invasive blood biomarkers for early MCI detection.

Purpose of the Study:

  • To retrospectively assess the association between red blood cell (RBC) indices and MCI in an elderly Chinese population.
  • To identify the optimal hematologic marker for MCI detection.

Main Methods:

  • A matched case-control study involving 85 pairs of MCI subjects and healthy controls.
  • Analysis of RBC indices including hemoglobin (HGB), hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin concentration (MCHC), and red cell distribution width-standard deviation (RDW-SD).
  • Conditional logistic regression and receiver operating characteristic (ROC) curve analysis were employed.

Main Results:

  • Significant differences in HGB and RDW-SD were observed between MCI and control groups (P < 0.001).
  • Higher HGB was associated with a lower risk of MCI (adjusted OR: 0.831), while higher RDW-SD indicated a higher risk (adjusted OR: 1.575).
  • The combination of HGB and RDW-SD demonstrated the highest diagnostic efficacy (AUC = 0.842), with specific thresholds achieving 92% sensitivity and 89% specificity.

Conclusions:

  • Lower HGB and higher RDW-SD are independently associated with increased MCI risk.
  • The combined use of HGB and RDW-SD significantly improves classification accuracy for differentiating MCI from healthy controls.
  • Further prospective studies are warranted to validate HGB and RDW-SD as potential biomarkers for early Alzheimer's disease diagnosis.

Related Concept Videos